Indolfi, C.; Klain, A.; Dinardo, G.; Grella, C.; Di Filippo, P.; Fatica, I.; Napolano, V.; Decimo, F.; Miraglia del Giudice, M.
Azelastine–Fluticasone Combination Therapy in Allergic Rhinitis: Current Evidence and Clinical Implications in Children and Adults. Pharmaceuticals 2025, 18, 1624.
https://doi.org/10.3390/ph18111624
AMA Style
Indolfi C, Klain A, Dinardo G, Grella C, Di Filippo P, Fatica I, Napolano V, Decimo F, Miraglia del Giudice M.
Azelastine–Fluticasone Combination Therapy in Allergic Rhinitis: Current Evidence and Clinical Implications in Children and Adults. Pharmaceuticals. 2025; 18(11):1624.
https://doi.org/10.3390/ph18111624
Chicago/Turabian Style
Indolfi, Cristiana, Angela Klain, Giulio Dinardo, Carolina Grella, Pierluigi Di Filippo, Ilaria Fatica, Vincenzo Napolano, Fabio Decimo, and Michele Miraglia del Giudice.
2025. "Azelastine–Fluticasone Combination Therapy in Allergic Rhinitis: Current Evidence and Clinical Implications in Children and Adults" Pharmaceuticals 18, no. 11: 1624.
https://doi.org/10.3390/ph18111624
APA Style
Indolfi, C., Klain, A., Dinardo, G., Grella, C., Di Filippo, P., Fatica, I., Napolano, V., Decimo, F., & Miraglia del Giudice, M.
(2025). Azelastine–Fluticasone Combination Therapy in Allergic Rhinitis: Current Evidence and Clinical Implications in Children and Adults. Pharmaceuticals, 18(11), 1624.
https://doi.org/10.3390/ph18111624
